Iijima H - Search Results

1

Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.

Seko Y, Sumida Y, Sasaki K, Itoh Y, Iijima H, Hashimoto T, Ishii S, Inagaki N. Seko Y, et al. Among authors: iijima h. J Gastroenterol. 2018 Jan;53(1):140-151. doi: 10.1007/s00535-017-1364-8. Epub 2017 Jul 1. J Gastroenterol. 2018. PMID: 28669071

2

Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.

Kadowaki T, Marubayashi F, Yokota S, Katoh M, Iijima H. Kadowaki T, et al. Among authors: iijima h. Expert Opin Pharmacother. 2015 May;16(7):971-81. doi: 10.1517/14656566.2015.1032249. Epub 2015 Apr 10. Expert Opin Pharmacother. 2015. PMID: 25861982

3

Safety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus: post hoc subgroup analyses according to body mass index in a 52-week open-label study.

Inagaki N, Goda M, Yokota S, Maruyama N, Iijima H. Inagaki N, et al. Among authors: iijima h. Expert Opin Pharmacother. 2015;16(11):1577-91. doi: 10.1517/14656566.2015.1055250. Epub 2015 Jun 24. Expert Opin Pharmacother. 2015. PMID: 26104600 Clinical Trial.

4

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus.

Iijima H, Kifuji T, Maruyama N, Inagaki N. Iijima H, et al. Adv Ther. 2015 Aug;32(8):768-82. doi: 10.1007/s12325-015-0234-0. Epub 2015 Aug 18. Adv Ther. 2015. PMID: 26280756 Free PMC article. Clinical Trial.

5

Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus.

Inagaki N, Goda M, Yokota S, Maruyama N, Iijima H. Inagaki N, et al. Among authors: iijima h. Adv Ther. 2015 Nov;32(11):1085-103. doi: 10.1007/s12325-015-0255-8. Epub 2015 Nov 3. Adv Ther. 2015. PMID: 26530268 Free PMC article. Clinical Trial.

6

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus.

Inagaki N, Harashima S, Maruyama N, Kawaguchi Y, Goda M, Iijima H. Inagaki N, et al. Among authors: iijima h. Cardiovasc Diabetol. 2016 Jun 18;15:89. doi: 10.1186/s12933-016-0407-4. Cardiovasc Diabetol. 2016. PMID: 27316668 Free PMC article. Clinical Trial.

7

Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus.

Tanaka H, Takano K, Iijima H, Kubo H, Maruyama N, Hashimoto T, Arakawa K, Togo M, Inagaki N, Kaku K. Tanaka H, et al. Among authors: iijima h. Adv Ther. 2017 Feb;34(2):436-451. doi: 10.1007/s12325-016-0457-8. Epub 2016 Dec 15. Adv Ther. 2017. PMID: 27981497 Free PMC article. Clinical Trial.

8

Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Iijima H, Watanabe Y, Gouda M. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2017 Jun;19(6):874-882. doi: 10.1111/dom.12898. Epub 2017 Mar 31. Diabetes Obes Metab. 2017. PMID: 28177187 Free PMC article. Clinical Trial.

9

Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Watanabe Y, Gouda M, Iijima H. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2018 Jan;20(1):77-84. doi: 10.1111/dom.13038. Epub 2017 Jul 31. Diabetes Obes Metab. 2018. PMID: 28608617 Free PMC article.

10

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Gouda M, Iijima H, Watanabe Y. Kadowaki T, et al. Among authors: iijima h. Diabetes Obes Metab. 2018 Feb;20(2):453-457. doi: 10.1111/dom.13079. Epub 2017 Sep 15. Diabetes Obes Metab. 2018. PMID: 28786530 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,189 results

Search Page

Filters